TIZIANA LIFE SCIENCES LTD
TLSA · NASDAQ
Updated at 2026-10-15 08:21:23
- Today's High
- $1.08
- Today’s Low
- $1.03
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.06
- Previous Close
- $1.05
- Volume
- 581.34K
- Market Cap
- $134.72M
- P/E Ratio
- --
- EPS
- $-0.15
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 14/15 CONDUIT STREET, LONDON, UNITED KINGDOM, W1S 2XJ
- Country
- GB
- Listing Date
- 2018-11-20
- Fiscal Year End
- December
- Shares Outstanding
- 127.26M
- CIK
- 0001723069
- Website
- www.tizianalifesciences.com
Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the UK.
Financial Metrics
Revenue
2026-03-31
--
2025-09-30
--
2025-06-30
--
2025-03-31
--
Operating Expenses
2026-03-31
$12.18M
2025-09-30
$8.86M
2025-06-30
$8.86M
2025-03-31
$9.13M
Net Income
2026-03-31
-$12.79M
2025-09-30
-$5.63M
2025-06-30
-$5.63M
2025-03-31
-$7.2M
Net Profit Margin
2026-03-31
--
2025-09-30
--
2025-06-30
--
2025-03-31
--
Earnings Per Share
2026-03-31
--
2025-09-30
$-0.05
2025-06-30
--
2025-03-31
$-0.07
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-03-31
-$12.18M
2025-09-30
-$5.54M
2025-06-30
-$5.54M
2025-03-31
-$8.69M
Effective Tax Rate
2026-03-31
--
2025-09-30
--
2025-06-30
--
2025-03-31
17.76%
| Item | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | -- | -- | -- | -- |
| Operating Expenses | $12.18M | $8.86M | $8.86M | $9.13M |
| Net Income | -$12.79M | -$5.63M | -$5.63M | -$7.2M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | -- | $-0.05 | -- | $-0.07 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$12.18M | -$5.54M | -$5.54M | -$8.69M |
| Effective Tax Rate | -- | -- | -- | 17.76% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.